{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:47:51Z","timestamp":1790905671474,"version":"4.1.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,1,1]],"date-time":"2007-01-01T00:00:00Z","timestamp":1167609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,1]]},"DOI":"10.1016\/j.vaccine.2006.09.083","type":"journal-article","created":{"date-parts":[[2006,10,11]],"date-time":"2006-10-11T07:38:46Z","timestamp":1160552326000},"page":"1334-1341","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs"],"prefix":"10.1016","volume":"25","author":[{"given":"Shinya","family":"Fukumoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoh","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Okamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Bannai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikuo","family":"Igarashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuenan","family":"Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.vaccine.2006.09.083_bib1","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/vr.142.7.168","article-title":"Canine piroplasmosis due to Babesia gibsoni: clinical and morphological aspects","volume":"142","author":"Casapulla","year":"1998","journal-title":"Vet Rec"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.083_bib2","doi-asserted-by":"crossref","first-page":"692","DOI":"10.2307\/3284248","article-title":"Clinical, anatomic, and immunopathologic characterization of Babesia gibsoni infection in the domestic dog (Canis familiaris)","volume":"83","author":"Wozniak","year":"1997","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2006.09.083_bib3","first-page":"111","article-title":"Babesia gibsoni infections in dogs","volume":"3","author":"Yamane","year":"1993","journal-title":"J Protozool Res"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.083_bib4","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1939-165X.2001.tb00429.x","article-title":"Babesia gibsoni infection in a dog from Indiana","volume":"30","author":"Irizarry-Rovira","year":"2001","journal-title":"Vet Clin Pathol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.083_bib5","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2460\/javma.2002.220.325","article-title":"Babesia gibsoni infection among dogs in the southeastern United States","volume":"220","author":"Macintire","year":"2002","journal-title":"J Am Vet Med Assoc"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.083_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1292\/jvms.55.503","article-title":"Immunosuppression in dogs naturally infected with Babesia gibsoni","volume":"55","author":"Adachi","year":"1993","journal-title":"J Vet Med Sci"},{"issue":"5","key":"10.1016\/j.vaccine.2006.09.083_bib7","doi-asserted-by":"crossref","first-page":"507","DOI":"10.2460\/javma.1982.180.05.507","article-title":"Clinical observations on Babesia gibsoni and Babesia canis infections in dogs","volume":"180","author":"Farwell","year":"1982","journal-title":"J Am Vet Med Assoc"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2460\/javma.2002.220.185","article-title":"Clinical and hematologic effects of experimental infection of dogs with recently identified Babesia gibsoni-like isolates from Oklahoma","volume":"220","author":"Meinkoth","year":"2002","journal-title":"J Am Vet Med Assoc"},{"issue":"26","key":"10.1016\/j.vaccine.2006.09.083_bib9","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1136\/vr.148.26.819","article-title":"Fatal Babesia gibsoni infection in a dog from Spain","volume":"148","author":"Suarez","year":"2001","journal-title":"Vet Rec"},{"issue":"7","key":"10.1016\/j.vaccine.2006.09.083_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0169-4758(99)01471-4","article-title":"Designing blood-stage vaccines against Babesia bovis and B. bigemina","volume":"15","author":"Brown","year":"1999","journal-title":"Parasitol Today"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib11","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/S1471-4922(02)00053-3","article-title":"T cells as mediators of protective immunity against liver stages of Plasmodium","volume":"19","author":"Tsuji","year":"2003","journal-title":"Trends Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.083_bib12","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1471-4922(01)02207-3","article-title":"A multilateral effort to develop DNA vaccines against falciparum malaria","volume":"18","author":"Kumar","year":"2002","journal-title":"Trends Parasitol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.083_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1568008023340488","article-title":"Prospects for a human Toxoplasma vaccine","volume":"2","author":"Bout","year":"2002","journal-title":"Curr Drug Targets Immune Endocr Metabol Disord"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2006.09.083_bib14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1016\/S0264-410X(00)00302-9","article-title":"Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine","volume":"19","author":"Roy","year":"2000","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2006.09.083_bib15","first-page":"115","article-title":"Tolerability and immune responses in humans to a PowderJect DNA vaccine for hepatitis B","volume":"104","author":"Swain","year":"2000","journal-title":"Dev Biol (Basel)"},{"issue":"5986","key":"10.1016\/j.vaccine.2006.09.083_bib16","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/311578a0","article-title":"Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells","volume":"311","author":"Bennink","year":"1984","journal-title":"Nature"},{"issue":"9","key":"10.1016\/j.vaccine.2006.09.083_bib17","doi-asserted-by":"crossref","first-page":"6418","DOI":"10.1128\/jvi.70.9.6418-6424.1996","article-title":"Oral immunization with a replication-deficient recombinant vaccinia virus protects mice against influenza","volume":"70","author":"Bender","year":"1996","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib18","doi-asserted-by":"crossref","first-page":"822","DOI":"10.4049\/jimmunol.157.2.822","article-title":"Recombinant polyepitope vaccines for the delivery of multiple CD8 cytotoxic T cell epitopes","volume":"157","author":"Thomson","year":"1996","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.09.083_bib19","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0166-6851(91)90167-5","article-title":"Studies using a recombinant vaccinia virus expressing the circumsporozoite protein of Plasmodium berghei","volume":"48","author":"Satchidanandam","year":"1991","journal-title":"Mol Biochem Parasitol"},{"issue":"Suppl.","key":"10.1016\/j.vaccine.2006.09.083_bib20","first-page":"109","article-title":"Evaluation of vaccines designed to induce protective cellular immunity against the Plasmodium yoelii circumsporozoite protein: vaccinia, pseudorabies, and Salmonella transformed with circumsporozoite gene","volume":"68","author":"Sedegah","year":"1990","journal-title":"Bull World Health Organ"},{"issue":"5","key":"10.1016\/j.vaccine.2006.09.083_bib21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0264-410X(97)00226-0","article-title":"Enhancement of MHC class I-restricted peptide-specific T cell induction by a DNA prime\/MVA boost vaccination regime","volume":"16","author":"Hanke","year":"1998","journal-title":"Vaccine"},{"issue":"7\u20138","key":"10.1016\/j.vaccine.2006.09.083_bib22","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0264-410X(01)00450-9","article-title":"Enhanced CD8 T cell immunogenicity and protective efficacy in a mouse malaria model using a recombinant adenoviral vaccine in heterologous prime-boost immunisation regimes","volume":"20","author":"Gilbert","year":"2002","journal-title":"Vaccine"},{"issue":"5514","key":"10.1016\/j.vaccine.2006.09.083_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.292.5514.69","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine","volume":"292","author":"Amara","year":"2001","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.083_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nm0498-397","article-title":"Enhanced immunogenicity for CD8+ T cell induction and complete protective efficacy of malaria DNA vaccination by boosting with modified vaccinia virus Ankara","volume":"4","author":"Schneider","year":"1998","journal-title":"Nat Med"},{"issue":"19\u201320","key":"10.1016\/j.vaccine.2006.09.083_bib25","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1016\/S0264-410X(03)00032-X","article-title":"Protection in dogs against visceral leishmaniasis caused by Leishmania infantum is achieved by immunization with a heterologous prime-boost regime using DNA and vaccinia recombinant vectors expressing LACK","volume":"21","author":"Ramiro","year":"2003","journal-title":"Vaccine"},{"issue":"7","key":"10.1016\/j.vaccine.2006.09.083_bib26","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1128\/JCM.39.7.2603-2609.2001","article-title":"Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay","volume":"39","author":"Fukumoto","year":"2001","journal-title":"J Clin Microbiol"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.083_bib27","first-page":"596","article-title":"High-level expression of truncated surface antigen P50 of Babesia gibsoni in insect cells by baculovirus and evaluation of its immunogenicity and antigenicity","volume":"10","author":"Fukumoto","year":"2003","journal-title":"Clin Diagn Lab Immunol"},{"issue":"5","key":"10.1016\/j.vaccine.2006.09.083_bib28","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1645\/0022-3395(2000)086[0956:MCOBGG]2.0.CO;2","article-title":"Morphological changes of Babesia gibsoni grown in canine red blood cell-substituted severe combined immune deficiency mice","volume":"86","author":"Fukumoto","year":"2000","journal-title":"J Parasitol"},{"key":"10.1016\/j.vaccine.2006.09.083_bib29","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2149\/tmh1973.6.15","article-title":"Pathophysiological findings on blood of Beagles experimentally infected with Babesia gibsoni","volume":"6","author":"Ishimine","year":"1978","journal-title":"Jap J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0378-1119(91)90434-D","article-title":"Efficient selection for high-expression transfectants with a novel eukaryotic vector","volume":"108","author":"Niwa","year":"1991","journal-title":"Gene"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib31","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1006\/bbrc.1997.6485","article-title":"Intramuscular injection of expression plasmid DNA is an effective means of long-term systemic delivery of interleukin-5","volume":"233","author":"Tokui","year":"1997","journal-title":"Biochem Biophys Res Commun"},{"issue":"21","key":"10.1016\/j.vaccine.2006.09.083_bib32","doi-asserted-by":"crossref","first-page":"7413","DOI":"10.1073\/pnas.84.21.7413","article-title":"Lipofection: a highly efficient, lipid-mediated DNA-transfection procedure","volume":"84","author":"Felgner","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.083_bib33","doi-asserted-by":"crossref","first-page":"2788","DOI":"10.1128\/jvi.64.6.2788-2795.1990","article-title":"Induction of protective immunity in animals vaccinated with recombinant vaccinia viruses that express PreM and E glycoproteins of Japanese encephalitis virus","volume":"64","author":"Yasuda","year":"1990","journal-title":"J Virol"},{"issue":"Pt 21","key":"10.1016\/j.vaccine.2006.09.083_bib34","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1242\/jeb.00642","article-title":"Prime-boost strategies for malaria vaccine development","volume":"206","author":"Dunachie","year":"2003","journal-title":"J Exp Biol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.09.083_bib35","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1645\/GE-147R","article-title":"Serodiagnosis of canine Babesia gibsoni infection by enzyme-linked immunosorbent assay with recombinant P50 expressed in Escherichia coli","volume":"90","author":"Fukumoto","year":"2004","journal-title":"J Parasitol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.09.083_bib36","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1128\/IAI.67.8.4143-4148.1999","article-title":"Roles of CD4(+) T cells and gamma interferon in protective immunity against Babesia microti infection in mice","volume":"67","author":"Igarashi","year":"1999","journal-title":"Infect Immun"},{"issue":"32","key":"10.1016\/j.vaccine.2006.09.083_bib37","doi-asserted-by":"crossref","first-page":"4595","DOI":"10.1016\/S0264-410X(01)00260-2","article-title":"A prime-boost immunisation regimen using DNA followed by recombinant modified vaccinia virus Ankara induces strong cellular immune responses against the Plasmodium falciparum TRAP antigen in chimpanzees","volume":"19","author":"Schneider","year":"2001","journal-title":"Vaccine"},{"issue":"9","key":"10.1016\/j.vaccine.2006.09.083_bib38","doi-asserted-by":"crossref","first-page":"5565","DOI":"10.1128\/IAI.69.9.5565-5572.2001","article-title":"Multistage multiantigen heterologous prime boost vaccine for Plasmodium knowlesi malaria provides partial protection in rhesus macaques","volume":"69","author":"Rogers","year":"2001","journal-title":"Infect Immun"},{"issue":"13","key":"10.1016\/j.vaccine.2006.09.083_bib39","doi-asserted-by":"crossref","first-page":"7648","DOI":"10.1073\/pnas.95.13.7648","article-title":"Boosting with recombinant vaccinia increases immunogenicity and protective efficacy of malaria DNA vaccine","volume":"95","author":"Sedegah","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"10.1016\/j.vaccine.2006.09.083_bib40","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1128\/IAI.72.3.1795-1798.2004","article-title":"Inhibitory effect of antiserum to surface antigen P50 of Babesia gibsoni on growth of parasite in SCID mice given canine red blood cells","volume":"72","author":"Fukumoto","year":"2004","journal-title":"Infect Immun"},{"issue":"6","key":"10.1016\/j.vaccine.2006.09.083_bib41","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nm881","article-title":"Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans","volume":"9","author":"McConkey","year":"2003","journal-title":"Nat Med"},{"issue":"4","key":"10.1016\/j.vaccine.2006.09.083_bib42","first-page":"557","article-title":"Immunization with recombinant surface antigen P50 of Babesia gibsoni expressed in insect cells induced parasite growth inhibition in dogs","volume":"12","author":"Fukumoto","year":"2005","journal-title":"Clin Diagn Lab Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X0601084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:15:14Z","timestamp":1759400114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X0601084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,1]]},"references-count":42,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2007,1]]}},"alternative-id":["S0264410X0601084X"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.09.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}